Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/7/2026

1. SPCX
2. MU
3. APTX:CN
4. SPY
5. IQMX
6. RIVN
7. MSFT
8. EROC
9. MSTR
10. CRNX

Go back to Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation
(NASDAQ: PLSE) Delayed: 29.11 --0 (-0%)
Previous Close $29.11    52 Week High $6.77 
Open $29.11    52 Week Low $4.03 
Day High $29.11    P/E N/A 
Day Low $29.11    EPS $0.00 
Volume 240